AI assistant
Sending…
Translational Development Acquisition Corp. — Director's Dealing 2024
Dec 20, 2024
33592_dirs_2024-12-20_045c0b34-b18f-43de-b0d4-af0c23c00b6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Translational Development Acquisition Corp. (TDAC)
CIK: 0001926599
Period of Report: 2024-12-20
Reporting Person: Kestenbaum Matthew (Director)
More from Translational Development Acquisition Corp.
Interim / Quarterly Report
2026
May 15
Annual Report
2026
May 11
Annual Report
2026
May 6
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Oct 10
Regulatory Filings
2025
Aug 14
Interim / Quarterly Report
2025
Aug 14
Major Shareholding Notification
2025
Jul 11
Interim / Quarterly Report
2025
May 15
Major Shareholding Notification
2025
May 14